Literature DB >> 28352059

Korean version of the Cough Symptom Score: clinical utility and validity for chronic cough.

Jae-Woo Kwon1, Ji-Yong Moon2, Sae-Hoon Kim3,4, Woo-Jung Song4, Min-Hye Kim5, Min-Gyu Kang4, Kyung-Hwan Lim6, So-Hee Lee4, Sang Min Lee7, Jin Young Lee8, Hyouk-Soo Kwon9, Kyung-Mook Kim10, Sang-Heon Kim2, Sang-Hoon Kim11, Jae-Won Jeong12, Cheol-Woo Kim13, Sang-Heon Cho4, Byung-Jae Lee8.   

Abstract

BACKGROUND/AIMS: The Cough Symptom Score (CSS) is a simple, useful tool for measuring cough severity. However, there is no standard Korean version of the CSS. We developed a Korean version of the CSS and evaluated its clinical utility and validity for assessing chronic cough severity.
METHODS: The CSS was adapted for Korean use following a forward-backward translation procedure. Patients with chronic cough enrolled from five university hospitals were graded using the CSS and a 100-mm linear visual analog scale (VAS) of cough severity at each visit. Patients completed the Leicester Cough Questionnaire (LCQ) upon presentation and completed the LCQ and Global Rating of Change at follow-up visits after 2 to 4 weeks. The concurrent validity, repeatability, and responsiveness of the Korean version of the CSS were determined.
RESULTS: Correlation coefficients between the CSS and LCQ, and between the CSS and VAS, were -0.66 and 0.52, respectively. There was a weak correlation between the scores for night and day symptoms (r = 0.24, p = 0.0006). The repeatability of the CSS in patients with no change in cough (n = 23) was high (intra-class correlation coefficient, 0.75; 95% confidence interval [CI], 0.51 to 0.88). Patients who reported an improvement in cough (n = 30) at follow-up visits had a significant improvement in the CSS (median, -2; 95% CI, -3 to -1; p = 0.0003).
CONCLUSIONS: The Korean version of the CSS correlated well with other tools for accessing cough severity in chronic cough patients. Therefore, it could be a reliable method for measuring chronic cough severity.

Entities:  

Keywords:  Chronic disease; Cough; Korean version of the Cough Symptom Score; Surveys and questionnaires

Mesh:

Year:  2017        PMID: 28352059      PMCID: PMC5583454          DOI: 10.3904/kjim.2016.132

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


INTRODUCTION

Cough is a common problem for which medical attention is sought. A way to assess cough severity or the effectiveness of cough management is needed, especially for chronic cough, defined as a cough lasting more than 8 weeks [1,2]. Outcomes often measured to assess cough include one or more of the following: cough severity, cough impact on quality of life, cough frequency, or cough sensitivity. However, these assessments are not based on standardized or valid measures [3]. Because there is limited and insufficient evidence of the reliability or concurrent validity of the different types of cough diaries and visual analog scale (VAS) scores, the American College of Chest Physicians guidelines suggested that cough-specific questionnaires, a VAS, or numeric rating scales should be used in a standard fashion [3-5]. The Cough Symptom Score (CSS) consists of two questions about the subjective recognition of cough frequency in the day and at night. The CSS is a subjective, self-completed questionnaire used to measure cough that has been used widely in many studies of cough [6-10]. It is simple and short, and seems to be more practical than cough-specific quality-of-life questionnaires in clinical practice. However, the CSS has not been validated for use among the Korean population. This study developed a Korean version of the CSS and compared its relationship with clinical parameters, as well as VAS or Leicester Cough Questionnaire (LCQ) scores, to determine its reliability, validity, and responsiveness for assessing chronic cough [7,11-13].

METHODS

Subjects

We enrolled patients with chronic cough from five university hospitals (Hanyang University Guri Hospital, Samsung Medical Center, Seoul National University Hospital, Seoul National University Bundang Hospital, and Kangwon National University Hospital) between May 2011 and October 2013 [13]. Chronic cough was defined as a cough lasting for more than 8 weeks. Patients aged < 15 or ≥ 70 years were excluded. Patients were graded using the CSS, LCQ, and a 100-mm linear VAS of cough severity (ranging from “no cough” to “worst cough”) at enrollment and follow-up visits after 2 to 4 weeks. The Global Rating of Change (GRC) was completed only at the follow-up visits after 2 to 4 weeks. The study protocol was approved by the Institutional Review Board of each participating hospital, and informed consent was obtained from all patients.

Cough Symptom Score

The CSS, which was proposed by Hsu et al. [8], and consists of two questions regarding subjective cough severity during the day and in the evening, has been used widely in many studies to assess cough frequency and severity, since there are no standard objective methods to measure cough frequency [8-10]. The scores for each question range from 0 to 5, and so the CSS total score ranges from 0 (no cough at all) to 10 (most severe cough). The CSS was adapted for Korean populations following a forward-backward translation procedure, with independent translations and counter-translations. The suitability of the wording and phrasing of the Korean version of the CSS was tested in three patients with coughs.

Leicester Cough Questionnaire

The LCQ is a cough-specific quality-of-life questionnaire containing 19 items that are divided into physical, psychological, and social domains [13]. A 7-point Likert scale is used to evaluate responses to each item, and the domain scores range from 1 to 7. The total score ranges from 3 to 21; a higher score indicates a better quality of life.

Global Rating of Change

The GRC assessment was performed to evaluate self-perceived changes in disease status since the first visit. Scores range from 7 (a great deal better) to –7 (a great deal worse) and status is classified as unchanged (–1, 0, 1), small change (–3, –2, 2, 3), moderate change (–5, –4, 5, 4), and large change (–7, –6, 7, 6) [14]. Scores of 4, 5, 6, and 7 are considered to represent a clinically significant improvement [15].

Validation

Concurrent validity indexes the validity of an instrument against other standards; this was assessed by correlating the CSS with LCQ and VAS scores. A correlation coefficient ≥ 0.4 is generally regarded as a moderate correlation, while correlations > 0.75 are considered as strong correlations. The relationship between the two questions regarding subjective cough severity, both during the day and in the evening, was assessed for internal consistency using Spearman correlation coefficient. The repeatability of the CSS was assessed in patients indicating no change (–1, 0, 1) in the GRC at follow-up visits over 2 to 4 weeks. Assuming no difference in the average score between the test and retest, and that the standard deviation of the total score was identical at each time point, 14 patients were required with 0.75 as the lower limit for high agreement with a 95% confidence interval (CI), in the expectation of a 0.9 intra-class correlation coefficient (ICC) [16]. An ICC ≥ 0.4 is generally regarded as a moderate correlation and an ICC > 0.75 denotes a strong correlation. The responsiveness of the CSS was assessed in those patients indicating clinical improvements (4, 5, 6, and 7) in the GRC upon follow-up visits after 2 to 4 weeks.

Statistical analysis

Patient characteristics are presented as mean ± SD for continuous variables and as relative frequencies for categorical variables. Each symptom score during the day and at night are shown as mean ± SD are scores are compared using the Wilcoxon signed-rank test. Spearman correlation coefficients between the CSS and LCQ scores were calculated to assess concurrent validity, since the CSS and two of the three LCQ domains did not follow a normal distribution. Internal consistency was evaluated using Spearman correlation coefficient between the two questions in the CSS. Repeatability was assessed by calculating the ICCs. Responsiveness was assessed using the Wilcoxon signed-rank test to compare CSS at baseline and after clinical improvement, since the CSS data did not follow a normal distribution. The statistical analysis was performed using SAS software version 9.3 (SAS Institute, Cary, NC, USA).

RESULTS

The study enrolled 207 patients with chronic cough and their characteristics are shown in Table 1 [13].
Table 1.

Patient characteristics (n = 207)

CharacteristicValue
Female sex126 (61)
Age, yr48.5 ± 13.8
Current smoker35 (16.9)
Duration of cough, yr1 (0.17–45)
Leicester Cough Questionnaire
 Physical4.3 ± 1.1
 Psychological3.7 ± 1.2
 Social4.0 ± 1.4
 Total12.1 ± 3.3
Cough Symptom Score4.9 ± 1.8
Visual analog scale5.5 ± 2.6

Values are presented as number (%), mean ± SD, or median (range).

The correlation coefficients of concurrent validity, determined in 202 patients, are shown in Table 2. The correlation coefficients between the CSS and LCQ ranged between –0.66 and –0.60. The CSS was also well correlated with VAS scores (r = 0.52, p < 0.0001) (Fig. 1). The scores for daytime symptoms were more closely related to LCQ quality of social life than were the scores for nighttime symptoms (r = –0.543, p < 0.0001 vs. r = –0.441, p < 0.0001). The scores for nighttime symptoms were more closely related to LCQ physical and psychological quality of life than were the scores of daytime symptoms (r = –0.557, p < 0.0001 vs. r = –0.416, p < 0.0001; r = –0.481, p < 0.0001 vs. r = –0.470, p < 0.0001, respectively).
Table 2.

Concurrent validity of the CSS, LCQ, and VAS

VariableCSSp value
LCQ
 Physical–0.61< 0.0001
 Psychological–0.60< 0.0001
 Social–0.61< 0.0001
 Total–0.66< 0.0001
VAS0.52< 0.0001

Spearman correlation coefficients.

CSS, Cough Symptom Score; LCQ, Leicester Cough Questionnaire; VAS, visual analog scale.

Figure 1.

Relationship between the Cough Symptom Score (CSS) and (A) Leicester Cough Questionnaire (LCQ) scores and (B) visual analog scale.

The internal consistency of the CSS (n = 207), given by Spearman correlation coefficient between the night and daytime symptom scores, was 0.24 (p = 0.0006) (Fig. 2). Symptom scores during the day were higher than those during the night (3.06 ± 1.13 vs. 1.80 ± 1.14, p < 0.0001).
Figure 2.

Distribution of daytime and nighttime Cough Symptom Score cough frequency scores. The color and number in each square indicate the number of patients. Spearman correlation coefficient between nighttime and daytime symptom scores was 0.24 (p = 0.0006).

The repeatability of the CSS in patients with no change in cough status (n = 23) was high (ICC, 0.75; 95% CI, 0.51 to 0.88). Patients who reported an improvement in cough (n = 30) at follow-up also had a significant improvement in the CSS (Table 3).
Table 3.

Responsiveness to clinical improvement in cough patients (n = 30)

VariableImprovement score95% CIp value
Leicester Cough Questionnaire[a]
 Physical0.920.44 to 1.390.0005
 Psychological1.290.64 to 1.930.0004
 Social1.170.57 to 1.770.0005
 Total3.371.71 to 5.030.0003
 Cough Symptom Score[b]–2–3 to –10.0003

CI, confidence interval.

Paired t test.

Wilcoxon signed-rank test.

DISCUSSION

The Korean version of the CSS correlated well with patients’ perceptions, as shown by VAS and cough-specific quality-of-life questionnaire scores. The Korean version of the CSS appears to have acceptable repeatability and responsiveness to change. Evaluating the severity of chronic cough is important for both research and clinical practice, because the accuracy of the diagnosis is given by the response to specific treatment in most cases [11]. However, evaluation of cough using validated methods remains challenging for both clinicians and researchers [6]. To evaluate the efficacy of cough-modifying agents optimally, investigators are recommended to use both subjective and objective method because they have the potential to measure different things [7]. Therefore, cough-specific quality-of-life questionnaires, such as the LCQ, are usually recommended for assessing cough severity [6,10], because these questionnaires have been widely used, show repeatability and responsiveness, and correlate with cough frequency in chronic cough [9-13,17]. However cough-specific quality-of-life questionnaires take a relatively long time to complete and their use is not convenient in daily practice. Although a VAS is very convenient and easy to use, the correlations between VAS and objective cough measurements or quality-of-life scores are inconsistent [6]. In comparison, the CSS is a simple tool for scoring subjectively experienced cough frequency and there are several different forms of the instrument [7,8,16,18]. And thus, a standard Korean version of the CSS is needed. Several studies have shown moderate correlations between objective cough frequency and CSS [8-10], but no studies have examined the correlations between CSS and LCQ or VAS scores. The demographic characteristics of the study population were similar to those in a previous report on Korean patients with chronic cough, in which middle-aged women were predominant [19]. There were differences in the subjective cough frequency between daytime and nighttime in this study, although there was a weak correlation. This suggests that there are diurnal changes in cough severity in many patients with chronic cough. This is consistent with the results of several previous reports on patients with chronic cough, which showed that the daytime CSS was higher than nighttime scores, and cough frequency indexed by objective cough monitoring was also higher during the daytime [9,10]. Using an objective cough measurement, Marsden et al. [10] showed that coughing rates during the day and at night were different in asthmatic patients and showed a moderate correlation. In addition, the current study showed that nighttime subjective cough frequency was related more to the psychological aspects of quality of life, while the daytime subjective cough frequency was related more to the social aspects of quality of life. In conclusion, we developed a Korean version of the CSS, which correlated well with VAS and LCQ scores in patients with chronic cough. This study suggests that the Korean version of the CSS could be used to evaluate the results of interventions for the management of chronic cough, and is a useful parameter for evaluating chronic cough in the clinic and for research purposes.
  19 in total

1.  Cough frequency, cough sensitivity and health status in patients with chronic cough.

Authors:  Surinder S Birring; Sergio Matos; Ronnak B Patel; Benjamin Prudon; David H Evans; Ian D Pavord
Journal:  Respir Med       Date:  2005-11-02       Impact factor: 3.415

2.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

3.  Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder.

Authors:  J Y Hsu; R A Stone; R B Logan-Sinclair; M Worsdell; C M Busst; K F Chung
Journal:  Eur Respir J       Date:  1994-07       Impact factor: 16.671

Review 4.  An empiric integrative approach to the management of cough: ACCP evidence-based clinical practice guidelines.

Authors:  Melvin R Pratter; Christopher E Brightling; Louis Philippe Boulet; Richard S Irwin
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 5.  Evaluating cough assessment tools: a systematic review.

Authors:  Kristine M Schmit; Remy R Coeytaux; Adam P Goode; Douglas C McCrory; William S Yancy; Alex R Kemper; Vic Hasselblad; Brooke L Heidenfelder; Gillian D Sanders
Journal:  Chest       Date:  2013-12       Impact factor: 9.410

6.  A comparison of objective and subjective measures of cough in asthma.

Authors:  Paul A Marsden; Jaclyn A Smith; Angela A Kelsall; Emily Owen; Jonathan R Naylor; Deborah Webster; Helen Sumner; Uazman Alam; Kevin McGuinness; Ashley A Woodcock
Journal:  J Allergy Clin Immunol       Date:  2008-10-08       Impact factor: 10.793

7.  A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response.

Authors:  Alyn H Morice; Adam D Jakes; Shoaib Faruqi; Surinder S Birring; Lorcan McGarvey; Brendan Canning; Jaclyn A Smith; Sean M Parker; Kian Fan Chung; Kefang Lai; Ian D Pavord; Jan van den Berg; Woo-Jung Song; Eva Millqvist; Michael J Farrell; Stuart B Mazzone; Peter Dicpinigaitis
Journal:  Eur Respir J       Date:  2014-09-03       Impact factor: 16.671

8.  Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire.

Authors:  J W H Kocks; M G Tuinenga; S M Uil; J W K van den Berg; E Ståhl; T van der Molen
Journal:  Respir Res       Date:  2006-04-07

9.  Reliability and validity of a korean version of the leicester cough questionnaire.

Authors:  Jae Woo Kwon; Ji Yong Moon; Sae Hoon Kim; Woo Jung Song; Min Hye Kim; Min Gyu Kang; Kyung Hwan Lim; So Hee Lee; Sang Min Lee; Jin Young Lee; Hyouk Soo Kwon; Kyung Mook Kim; Sang Heon Kim; Sang Hoon Kim; Jae Won Jeong; Cheol Woo Kim; Sang Heon Cho; Byung Jae Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-12-18       Impact factor: 5.764

10.  Defining Chronic Cough: A Systematic Review of the Epidemiological Literature.

Authors:  Woo Jung Song; Yoon Seok Chang; Shoaib Faruqi; Min Koo Kang; Ju Young Kim; Min Gyu Kang; Sujeong Kim; Eun Jung Jo; Seung Eun Lee; Min Hye Kim; Jana Plevkova; Heung Woo Park; Sang Heon Cho; Alyn H Morice
Journal:  Allergy Asthma Immunol Res       Date:  2015-09-18       Impact factor: 5.764

View more
  4 in total

1.  Sensitivity-to-change and predictive validity of the Cervantes Short-Form (C-SF) questionnaire in postmenopausal women.

Authors:  María Fasero; Javier Rejas-Gutiérrez; Pluvio J Coronado
Journal:  Arch Gynecol Obstet       Date:  2022-09-20       Impact factor: 2.493

2.  HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.

Authors:  Sang Won Yoon; Myung Jae Park; Chin Kook Rhee; Joo Hun Park; Sang Yeub Lee; Do Jin Kim; Dong Gyu Kim; Jae Yeol Kim
Journal:  Korean J Intern Med       Date:  2019-04-09       Impact factor: 2.884

3.  Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough.

Authors:  Sang Pyo Lee; Sang Min Lee; Byung-Jae Lee; Sung-Yoon Kang
Journal:  J Korean Med Sci       Date:  2022-09-19       Impact factor: 5.354

4.  Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non-small cell lung cancer patients after surgery.

Authors:  Rongjia Lin; Guowei Che
Journal:  Thorac Cancer       Date:  2018-02-27       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.